FR940503-0-00050 FR940503-0-00011 DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration 21 CFR Part 520 Oral Dosage Form New Animal Drugs; Change of Sponsor AGENCY: Food and Drug Administration, HHS. ACTION: Final rule. SUMMARY: The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect a change of sponsor for three new animal drug applications (NADA's) from SmithKline Beecham Animal Health to Solvay Animal Health, Inc. EFFECTIVE DATE: May 3, 1994. FOR FURTHER INFORMATION CONTACT: Benjamin A. Puyot, Center for Veterinary Medicine (HFV&hyph;130), Food and Drug Administration, 7500 Standish Pl., Rockville, MD 20855, 301&hyph;594&hyph;1646. SUPPLEMENTARY INFORMATION: SmithKline Beecham Animal Health, 1600 Paoli Pike, West Chester, PA 19380, has informed FDA that it has transferred ownership of, and all rights and interests in, approved NADA's 49&hyph;892, 126&hyph;232, and 140&hyph;909 to Solvay Animal Health, Inc., 1201 Northland Dr., Mendota Heights, MN 55120. Accordingly, FDA is amending the regulations in 21 CFR 520.2260a, 520.2260b, and 520.2260c to reflect the change of sponsor. List of Subjects in 21 CFR Part 520 Animal drugs. Therefore, under the Federal Food, Drug, and Cosmetic Act and under authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR part 520 is amended as follows: PART 520_ORAL DOSAGE FORM NEW ANIMAL DRUGS 1. The authority citation for 21 CFR part 520 continues to read as follows: Authority : Sec. 512 of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 360b). ยง520.2260a [Amended] 2. Section 520.2260a Sulfamethazine oblets and boluses is amended in paragraph (b)(1) by removing ``053571'' and adding in its place ``053501''. ยง520.2260b [Amended] 3. Section 520.2260b Sulfamethazine sustained-release boluses is amended in paragraph (b)(1) by removing ``053571'' and adding in its place ``053501''. ยง520.2260c [Amended] 4. Section 520.2260c Sulfamethazine sustained-release tablets is amended in paragraph (a) by removing ``053571'' and adding in its place ``053501''. Dated: April 22, 1994. Robert C. Livingston, Director, Office of New Animal Drug Evaluation, Center for Veterinary Medicine. [FR Doc. 94&hyph;10458 Filed 5&hyph;2&hyph;94; 8:45 am] BILLING CODE 4160&hyph;01&hyph;F
